![PDF) Children and adolescent acceptability of a new device system to administer human growth hormone - A pilot study PDF) Children and adolescent acceptability of a new device system to administer human growth hormone - A pilot study](https://www.researchgate.net/profile/Anne-Marie-Kappelgaard/publication/228437900/figure/fig1/AS:601653187203077@1520456706254/figure-fig1_Q320.jpg)
PDF) Children and adolescent acceptability of a new device system to administer human growth hormone - A pilot study
![PDF) Children and adolescent acceptability of a new device system to administer human growth hormone - A pilot study PDF) Children and adolescent acceptability of a new device system to administer human growth hormone - A pilot study](https://www.researchgate.net/profile/Anne-Marie-Kappelgaard/publication/228437900/figure/tbl2/AS:601653191405592@1520456707843/Percentage-of-patients-reporting-the-top-mark-4-and-mean-score-when-evaluating-the_Q320.jpg)
PDF) Children and adolescent acceptability of a new device system to administer human growth hormone - A pilot study
![NordiPen used with 5 mg, 10 mg and 15 mg Norditropin SimpleXx cartridges | Therapeutic Goods Administration (TGA) NordiPen used with 5 mg, 10 mg and 15 mg Norditropin SimpleXx cartridges | Therapeutic Goods Administration (TGA)](https://www.tga.gov.au/sites/default/files/alerts-device-nordipen-130723-3.jpg)
NordiPen used with 5 mg, 10 mg and 15 mg Norditropin SimpleXx cartridges | Therapeutic Goods Administration (TGA)
![NordiPen used with 5 mg, 10 mg and 15 mg Norditropin SimpleXx cartridges | Therapeutic Goods Administration (TGA) NordiPen used with 5 mg, 10 mg and 15 mg Norditropin SimpleXx cartridges | Therapeutic Goods Administration (TGA)](https://www.tga.gov.au/sites/default/files/alerts-device-nordipen-130723-2.jpg)